1. Denmark Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Ambu A/S

Ambu A/S

AMBFF
Ambu A/SUS flagOther OTC
9.90
USD
- -
- -
2.62BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
5.91
6.68
7.86
8.79
9.94
10.72
11.54
14.47
15.94
17.5
18.33
20.24
- -
22.36
Basic EPS, GAAP
0.2
0.64
0.63
1.05
1.27
1.39
1.3
0.98
0.98
0.37
0.64
0.88
- -
1.35
Free Cash Flow per Basic Share
0.52
0.73
0.87
1.31
1.95
1.31
1.11
-0.55
-1.02
-1.8
0.74
1.97
- -
1.41
Dividend per Share
0.15
0.06
0.19
0.19
0.32
0.38
0.41
0.39
0.29
0.3
- -
- -
- -
0.38
Book Value per Share
2.73
3.2
3.47
3.17
4.5
6.96
7.9
9.03
14.98
15.28
19.89
20.46
- -
22.02
Tangible Book Value per Share
-1.16
-0.62
-0.21
-1.05
0.27
-3.12
-2.48
-2.28
2.81
2.53
6.84
8.88
- -
10.02
Basic Weighted Avg Shares
234
237
240
237
237
243
244
247
252
254
260
266
267
267
Sales/Revenue/Turnover
1,383
1,584
1,889
2,084
2,355
2,606
2,820
3,567
4,013
4,444
4,775
5,391
- -
5,958
Operating Margin (%)
11.42
12.5
12.76
17.08
19.53
21.6
17.02
12
8.47
2.75
6.32
11.96
- -
13.16
Depreciation Expense
74
88
96
102
105
115
109
181
216
351
348
696
- -
704
Net Income, GAAP
48
151
152
250
301
337
317
241
247
93
168
235
- -
359
Effective Tax Rate (%)
31.43
27.4
29.3
23.31
23.41
27.53
23.24
25.16
19.81
14.68
20
21.67
- -
15.33
Profit Margin (%)
3.47
9.53
8.05
12
12.78
12.93
11.24
6.76
6.15
2.09
3.52
4.36
- -
6.03
Working Capital
298
351
400
381
-284
511
154
197
628
1,143
1,066
1,578
- -
1,929
LT Debt
753
702
700
925
83
1,304
1,151
1,401
760
1,766
512
483
- -
459
Total Equity
651
854
1,036
990
1,279
1,882
2,182
2,372
3,952
4,261
5,393
5,594
- -
5,905
Return on Invested Capital (%)
9.73
9.07
9.46
13.94
17.13
15.29
11.06
8.91
6.37
1.91
4.01
8.32
- -
10.32
Return on Capital (%)
5.83
11.92
10.8
16.28
18.15
14.81
10.92
7.75
6.48
2.33
3.77
4.35
- -
6.28
Return on Common Equity (%)
7.69
21.62
19.11
31.55
33.1
24.43
17.49
11.59
8.24
2.43
3.71
4.42
- -
6.28

Capital Structure

FRC

•

in mil. unless spec.
Dec'25
Mar'25
Jun'25
ST Debt
75
76
75
LT Borrowings
- -
- -
- -
LT Finance Leases
489
478
459
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
266
266
266
Market Capitalization
38,409
35,609
26,374

Working Capital

FRC

•

in mil. unless spec.
Dec'25
Mar'25
Jun'25
Total Current Assets
2,808
2,891
2,943
Cash, Cash Equivalents & STI
588
640
751
Accounts Receivable, Net
826
877
852
Inventories
1,228
1,214
1,193
Total Current Liabilities
1,078
1,003
1,014
Payables & Accruals
- -
- -
- -
ST Debt
75
76
75
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,254
1,367
1,383
1,387
5,391
2025
1,510
1,554
1,507
- -
- -
2026
1,558
1,573
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.35
0.54
0.5
-0.51
0.88
2025
0.68
0.71
0.46
- -
- -
2026
0.44
0.46
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
0.3
0.08
- -
- -
- -
2026
0.34
0.08
- -
- -
- -

Company Description

APIChat
CEO
Britt Meelby Jensen
Full Time Employees
5,000
Sector
Healthcare
Industry
Medical - Devices
Address
Baltorpbakken 13 Ballerup Denmark 2750
IPO Date
May 19, 2017
Website
ambu.com
Similar Companies
Paxman AB (publ) (PXMBF)
MicroPort Scientific Corporation (0853.HK)
Neola Medical AB (publ) (NEOLA.ST)
Varex Imaging Corporation (VREX)
Abbott Laboratories (ABT)
Intelligent Ultrasound Group plc (IUG.L)
Business
Ambu A/S develops, manufactures and markets single-use endoscopy solutions, diagnostic and life-supporting equipment to hospitals, private practices and rescue services worldwide; its core offerings span Endoscopy Solutions, including single-use flexible and semi-rigid endoscopes, video laryngoscopes and integrated systems such as aScope 5 Broncho, aScope 5 Uretero, aScope 5 Cysto HD cysto-nephroscopes, aScope Gastro, SureSight Connect and aBox 2 across pulmonology, urology, ear-nose-throat (ENT) and gastroenterology (GI) segments; and Anesthesia & Patient Monitoring products, comprising ventilation devices like the legacy Ambu bag resuscitator, disposable electrodes for ECG and neurophysiological mapping, and patient monitoring solutions. The company operates globally with North America contributing over 50% of revenue, followed by Europe and Rest of World (Asia Pacific, Latin America), through production sites in the USA, China, Malaysia and Mexico; it is headquartered in Ballerup, Denmark, and was founded in 1937. Ambu pursues strategic growth via its ZOOM AHEAD initiative launched in 2025, raising long-term organic revenue CAGR targets to 11-13% through FY 2029/30 (Endoscopy Solutions at 15-20%, Anesthesia & Patient Monitoring at 3-5%) and EBIT margin to +20%, building on the ZOOM IN strategy's success in achieving debt-free status, double-digit growth and strong cash flow; recent advancements include FDA clearance for aScope 5 Cysto HD in Q3 2024/25, expansion of SureSight Connect to pediatric patients, launch of the Ambu Recircle Program for endoscope recycling in key markets (UK, US, Germany, France) and plans for acquisitions in FY 2025/26 following financial stabilization.

Company News

APIChat

  • seekingalpha.com

    Ambu A/S (AMBBY) Q1 2026 Earnings Call Transcript

  • seekingalpha.com

    Ambu A/S (AMBBY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

  • seekingalpha.com

    Ambu A/S (AMBBY) Shareholder/Analyst Call Prepared Remarks Transcript

  • seekingalpha.com

    Ambu A/S (AMBBY) Q4 2025 Earnings Call Transcript

  • https://thefly.com

    Ambu upgraded to Buy from Hold at Nordea

  • seekingalpha.com

    Ambu A/S (AMBFF) Q4 2024 Earnings Call Transcript

  • seekingalpha.com

    Ambu A/S (AMBFF) Q1 2024 Earnings Call Transcript

  • seekingalpha.com

    Ambu A/S (AMBFF) Q2 2023 Earnings Call Transcript

  • seekingalpha.com

    Ambu A/S (AMBFF) Q4 2022 Earnings Call Transcript